Articles

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara
Division of Hematology, AOU “Policlinico V. Emanuele”, Catania
Department of Oncology, Transplants and Advanced Technologies, Section of Haematology, University of Pisa
Department of Oncology, Transplants and Advanced Technologies, Section of Haematology, University of Pisa
Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena
Division of Hematology, Azienda Ospedaliero Universitaria Careggi, Florence
Division of Hematology, Spedali Civili Hospital and University, Brescia
Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome
Department of Oncology, Civic Hospital, Noale, Venice
Division of Hematology, Ospedale Civile, Piacenza
Division of Hematology, Department of Hematology and Oncology, Niguarda Hospital, Milan
Division of Medical Oncology A, National Cancer Institute, Aviano
Divisions of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia
Department of Hematology, Local Health Unit of Pescara
Division of Hematology, Ospedale di Reggio Calabria
Hematology Unit, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara
Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena
Division of Hematology, AOU “Policlinico V. Emanuele”, Catania
Vol. 100 No. 4 (2015): April, 2015 https://doi.org/10.3324/haematol.2014.108183